Q8VDM1
Gene name |
Zgpat (Kiaa1847) |
Protein name |
Zinc finger CCCH-type with G patch domain-containing protein |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:229007 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8VDM1
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8VDM1-F1 | Predicted | AlphaFoldDB |
15 variants for Q8VDM1
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388616744 | 18 | Q>* | No | EVA | |
| rs3388604493 | 135 | A>V | No | EVA | |
| rs3388613468 | 174 | K>N | No | EVA | |
| rs3388617257 | 306 | F>L | No | EVA | |
| rs3388616746 | 319 | K>T | No | EVA | |
| rs247387217 | 322 | V>I | No | EVA | |
| rs247387217 | 322 | V>L | No | EVA | |
| rs3388616724 | 385 | P>H | No | EVA | |
| rs48076297 | 391 | P>S | No | EVA | |
| rs3388618941 | 452 | D>Y | No | EVA | |
| rs3392634484 | 458 | E>V | No | EVA | |
| rs3392645325 | 483 | R>L | No | EVA | |
| rs3392645341 | 484 | Q>P | No | EVA | |
| rs3388614224 | 501 | K>M | No | EVA | |
| rs3388616794 | 508 | M>I | No | EVA |
No associated diseases with Q8VDM1
5 regional properties for Q8VDM1
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | TRAM domain | 504 - 580 | IPR002792 |
| domain | Elp3/MiaA/NifB-like, radical SAM core domain | 250 - 490 | IPR006638 |
| domain | Radical SAM | 91 - 584 | IPR007197 |
| domain | Methylthiotransferase, N-terminal | 93 - 222 | IPR013848 |
| conserved_site | Methylthiotransferase, conserved site | 254 - 274 | IPR020612 |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
6 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA-binding transcription factor activity | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. |
| DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
| DNA-binding transcription repressor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II. |
| metal ion binding | Binding to a metal ion. |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
| sequence-specific DNA binding | Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of DNA-templated transcription | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| negative regulation of epidermal growth factor-activated receptor activity | Any process that stops, prevents, or reduces the frequency, rate or extent of EGF-activated receptor activity. |
| negative regulation of transcription by RNA polymerase II | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. |
| regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDEDNLETAL | QTYRAQLQQV | ELALGAGLDA | SEQADLRQLQ | GDLKELIELT | EASLLSVRKS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| KLLSTVDQES | PAQEDAEYLA | FQKAIAEEVE | APGAPCNDSE | TAPGSEVQPG | STSSALEEEE |
| 130 | 140 | 150 | 160 | 170 | 180 |
| EDPDLEELSG | AKVNAPYYSA | WGTLEYHNAM | VVGAEEAEDG | SACVRVLYLY | PTHKSLKPCP |
| 190 | 200 | 210 | 220 | 230 | 240 |
| FFLEGKCRFK | ENCRFSHGQV | VSVDELRPFQ | DPDLSLLQTG | SACLAKHQDG | LWHPARITDV |
| 250 | 260 | 270 | 280 | 290 | 300 |
| DNGYYTVKFD | SLLLKEAVVE | GDSILPPLRT | EATESSDSDT | GDASDSSYAR | VVEPSTVDTG |
| 310 | 320 | 330 | 340 | 350 | 360 |
| TCSSAFAGWE | VHTRGIGSKL | LVKMGYEFGK | GLGRHAEGRV | EPIHAVVLPR | GKSLDQCAEI |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LQKKTKRGQA | GSNRPPKCRR | SGSRPEGRPP | PRNVFDFLNE | KLQSQVPGTP | DAGVDTPERR |
| 430 | 440 | 450 | 460 | 470 | 480 |
| NKDMYHASKS | AKQALSLQLF | QTEEKIERTQ | RDIRGIQEAL | TRNTGRHNMT | TAHLQEKLEG |
| 490 | 500 | 510 | |||
| AQRQLGQLRA | QEADLQRKQR | KADTHRKMTE | F |